Evidence map›Paper›PMID 31615080›Full record

ArticleMicromachines2019

Integration of Hierarchical Micro-/Nanostructures in a Microfluidic Chip for Efficient and Selective Isolation of Rare Tumor Cells.

Shunqiang Wang, Younghyun Cho, Xuanhong Cheng, Shu Yang, Yi Liu, Yaling Liu

Abstract read
In one paragraph

Article in Micromachines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shunqiang WangDepartment of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, PA 18015, USA. sqwang1990@gmail.com.
Younghyun ChoDepartment of Materials Science and Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA. yhcho@sch.ac.kr.
Xuanhong ChengDepartment of Materials Science and Engineering, Lehigh University, Bethlehem, PA 18015, USA. xuc207@lehigh.edu.ORCID 0000-0002-6331-8572
Shu YangDepartment of Materials Science and Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA. shuyang@seas.upenn.edu.ORCID 0000-0001-8834-3320
Yi LiuSchool of Engineering, Dali University, Dali 671000, Yunnan, China. lyly1974@hotmail.com.
Yaling LiuDepartment of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, PA 18015, USA. yal310@lehigh.edu.

Funding

National Science Foundation CBET-1264808National Science Foundation DMS-1516236National Science Foundation PFI:AIR-TT 1701136NIH HHS EB015105, R01HL131750
6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are important clinical markers for both cancer early diagnosis and prognosis. Various techniques have been developed in the past decade to isolate and quantify these cells from the blood while microfluidic technology attracts significant attention due to better controlled microenvironment. When combined with advanced nanotechnologies, CTC isolation performance in microfluidic devices can be further improved. In this article, by extending the wavy-herringbone concept developed earlier in our team, we prepared a hierarchical microfluidic chip by introducing a uniform coating of nanoparticles with anti-epithelial cell adhesion molecule (EpCAM) on wavy microgrooves. This hierarchical structured platform not only maintains the capture purity of the wavy-herringbone structure but improves the capture efficiency thanks to the larger surface area to volume ratio brought by nanoparticles. Our results demonstrated a capture efficiency of almost 100% at a low shear rate of 60/s. Even at a higher shear rate of 400/s, the hierarchical micro/nanostructures demonstrated an enhancement of up to ~3-fold for capture efficiency (i.e., 70%) and ~1.5-fold for capture purity (i.e., 68%), compared to wavy-herringbone structures without nanoparticle coating. With these promising results, this hierarchical structured platform represents a technological advancement for CTC isolation and cancer care.

Indexed as

circulating tumor cell (CTC) isolationmicrofluidicsnanoparticles

Identifiers

PMID31615080
PMCPMC6843196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.